The latest COVID-19 variant, Pirola, has raised awareness among scientists due to its increased number of mutations. This new variant is suspected to be stronger and more contagious than previous strains. The concern arises as many Rapid At-Home COVID-19 tests have been reported to be ineffective in diagnosing positive COVID-19 samples due to viral load variance. PCR testing remains the most accurate form of testing for COVID-19, and combined with the iSWAB-RC-EL transport media, results can be achieved in less time.
The iSWAB-RC-EL is FDA Cleared for infectious disease detection of SARS-CoV-2 (from nasal and saliva samples) using legally marketed molecular diagnostic assays.
-Suitable for use without a nucleic acid extraction step.
-Samples are stable for several weeks at ambient temperature
-Non-hazardous, alcohol-free, and guanidine-free
-Efficient viral inactivation
Mawi DNA Technologies’ mission is to be a global leader in biological sample collection with the main objective of simplifying genomics and proteomics workflows.
For a Free Consultation with our Experts and more information on our products,
Alternative To Blood Samples Exome Sequencing Screening...
In a study published by the NPJ Genomic Medicine, Three young children presented with a neurodevelopmental disorder were studied to identify if there were pathogenic variants found in their ATG4D bi-...READ MORE
High-Efficiency Collection and Release Of Oral DNA Samples...
"The full release capacity functionality allows for adequate sample capture needed for DNA sample collection and processing." Mawi DNA Technologies, a medical device company fo...READ MORE
Meet The Mawi DNA Team We’ll be exhibiting at Booth…...
JOIN US AT ASHG | Nov 1-5, 2023 | Walter E. Washington Convention Center| Washington, D.C Mawi DNA Technologies improves the biological sample collection process with innovative technologies. Our ...READ MORE